Continue with FacebookLooking to list your PhD opportunities? Log in here.
radiotherapy PhD Projects, Programmes & Scholarships
We have 27 radiotherapy PhD Projects, Programmes & Scholarships
PhD saved successfully
Technological advancements in radiotherapy leading to dose delivery via FLASH
Over 25% of cancer patients in the UK receive radiotherapy, often delivered in multiple fractions over several weeks. This project seeks to improve radiotherapy treatment options through novel dose delivery, culminating in photon FLASH radiotherapy. Read more
Technological Advancements In Radiotherapy Leading To Dose Delivery via FLASH
Commercial partner: Teledyne e2v (Teledyne UK Limited). Over 25% of cancer patients in the UK receive radiotherapy, often delivered in multiple fractions over several weeks. Read more
Investigating the interplay between the immune consequences of pelvic radiotherapy, the gut microbiome and long-term side-effects
The North West has a higher prevalence of pelvic cancers compared to the rest of England. Around 40% of all people with cancer have curative-intent radiotherapy (RT) with 1 in 3 people having pelvic radiotherapy as an important component of their anti-cancer treatment. Read more
FLASH VHEE Radiotherapy Machine System Design
Supervisors. Alan Wheelhouse (ASTeC/STFC), James K. Jones (ASTeC/STFC), Valery Dolgashev (SLAC/Stanford Univ.), Roger M. Jones (University of Manchester/Cockcroft Institute). Read more
Cancer Biology: The role of Wnt signaling in glioblastoma therapeutic resistance
Glioblastoma is a deadly brain tumour treated with surgery, radiotherapy and chemotherapy with patient survival of 6-15 months. Read more
Interaction between DNA Polymerase theta inhibition and cGAS/STING activation
Emerging evidence suggests that the therapeutic effect of radiotherapy is at least partly dependent upon the induction of an anti-tumour immune response. Read more
Investigating the radiobiology of protons and BNCT in head and neck tumour treatment
Background. Head and neck squamous cell carcinoma (HNSCC) is the 6th most common cancer worldwide with an annual incidence of ~800,000 cases/year. Read more
Spatially Fractionated Radiotherapy in the Proton therapy research room
This project aims to design and add a capability for spatially fractionated radiotherapy (SFRT) to the research beamline in the research room in The Christie… Read more
Dual receptor binding radiopharmaceuticals in cancer: targeting the CXCR4 and ACKR3 chemokine receptors
Applications are invited for a fully funded 3,5 year full-time PhD studentship (including home tuition fees, annual stipend and consumables) starting on 1st February 2024. Read more
Computation modelling of biological response to radiation at tissue level for Proton Therapy
Proton Beam Therapy (PBT) is a radically new type of radiotherapy that has the potential to improve the precision and targeting of radiotherapy leading to fewer side effects, faster recovery and better outcomes for patients. Read more
MRC Enterprise Studentship Programme 2024 (Industrial CASE awards)
. Eight industrial CASE (iCASE) studentships are available for doctoral study at Oxford, to start in October 2024. Read more
MRC Enterprise Studentship Programme 2024 (Industrial CASE awards)
. Eight industrial CASE (iCASE) studentships are available for doctoral study at Oxford, to start in October 2024. Read more
Preclinical Development of Corticotroph Releasing Factor-1 (CRF1) Receptor PET Radioligands to Detect ACTH Producing Pituitary Adenomas
Pituitary adenomas are benign tumours which are challenging to detect and localise with conventional imaging methods. Positron Emission Tomography (PET) with amino acid transport tracers is being utilised to improve lesion detection and characterisation. Read more
PhD Position in Medicinal Radiochemistry at the University of Zurich
The University of Zurich (UZH) is seeking applications from candidates for a PhD in Medicinal Radiochemistry in the group of Prof. Read more
The Department of Oncology at the University of Oxford
The Department of Oncology employs multidisciplinary approaches from physics, biology, chemistry and mathematical modelling to investigate DNA biology and epigenetics, cell and environmental biology of tumour tissue, and both systemic and local immunological responses in cancer. Read more
- 1
- 2
